关注
Azar Shahraz, Ph.D.
Azar Shahraz, Ph.D.
Director at AstraZeneca
在 astrazeneca.com 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Investigating the pharmacodynamic durability of GalNAc–siRNA conjugates
CR Brown, S Gupta, J Qin, T Racie, G He, S Lentini, R Malone, M Yu, ...
Nucleic acids research 48 (21), 11827-11844, 2020
1842020
Effects of hierarchical surface roughness on droplet contact angle
MS Bell, A Shahraz, KA Fichthorn, A Borhan
Langmuir 31 (24), 6752-6762, 2015
1202015
A fuzzy sliding mode control approach for nonlinear chemical processes
A Shahraz, R Bozorgmehry Boozarjomehry
Control Engineering Practice 17 (5), 541-550, 2009
882009
A theory for the morphological dependence of wetting on a physically patterned solid surface
A Shahraz, A Borhan, KA Fichthorn
Langmuir 28 (40), 14227-14237, 2012
692012
Wetting on physically patterned solid surfaces: the relevance of molecular dynamics simulations to macroscopic systems
A Shahraz, A Borhan, KA Fichthorn
Langmuir 29 (37), 11632-11639, 2013
552013
Kinetics of Droplet Wetting Mode Transitions on Grooved Surfaces: Forward Flux Sampling
A Shahraz, A Borhan, KA Fichthorn
Langmuir 30 (51), 15442–15450, 2014
262014
A mechanistic systems pharmacology modeling platform to investigate the effect of PD-L1 expression heterogeneity and dynamics on the efficacy of PD-1 and PD-L1 blocking …
H Bazzazi, A Shahraz
Journal of Theoretical Biology 522, 110697, 2021
22021
System and method for distribution of sensors for emergency response
A Shahraz, S Khajehnajafi
US Patent 9,595,183, 2017
22017
24hr and random spot urine collections were comparable in assessing oxalate excretion and response to treatment in primary hyperoxaluria type 1
B Habtemariam, A Shahraz, J Lu, T McGregor
30th Annual Spring Clinical Meetings of the National Kidney Foundation, 2021
12021
NAR Breakthrough Article Investigating the pharmacodynamic durability of
CR Brown, S Gupta, J Qin, T Racie, G He, S Lentini, R Malone, M Yu, ...
Nucleic Acids Research 48 (21), 11827-11844, 2020
12020
System and method for distribution of sensors for emergency response
A Shahraz, S Khajehnajafi
US Patent 10,181,258, 2019
12019
Development of In Vitro-In Vivo Correlation for Long Acting Injectable Microsphere Formulations
A Shahraz, J Mullin, J Spires, V Lukacova, M Bolger, W Woltosz
AAPS Annual Meeting, 2017
12017
Charge transport through inhomogeneous polymeric materials
K Vakhshouri
The Pennsylvania State University, 2013
12013
A Mechanistic PK/PD Model of AZD0171 (Anti-LIF) to Support Phase II Dose Selection
A Shahraz, M Penney, J Candido, G Opoku-Ansah, M Neubauer, J Eyles, ...
CPT: Pharmacometrics & Systems Pharmacology, 2024
2024
Abstract LB277: Exposure response and safety analysis of osimertinib in combination with pemetrexed and platinum-based chemotherapy for the first-line treatment of locally …
J Yang, D Olabode, A Sawant, K Vishwanathan, S Bachina, A Todd, ...
Cancer Research 84 (7_Supplement), LB277-LB277, 2024
2024
Population Pharmacokinetics Analysis of Osimertinib in Combination with Pemetrexed and Platinum-Based Chemotherapy for the First-Line Treatment of Patients with Locally …
J Yang, D Olabode, A Sawant, K Vishwanathan, S Bachina, A Todd, ...
Fourteenth American Conference on Pharmacometrics (ACoP14), 2023
2023
Informative censoring is a potential cause of bias in oncology clinical trials
A Shahraz, J Hurtado, B Huang, K Vishwanathan
ASCPT 2023 Annual Meeting, 2023
2023
A mechanistic PK/PD model of AZD0171 (anti-LIF) to support phase 2 dose selection
A Shahraz, H Liu, F Hua, O Ojo, C Stovold, N Luheshi, A Phipps, ...
ASCPT 2023 Annual Meeting, 2023
2023
Tumor Size Modeling Enables Selection of the Phase 3 Dose and Schedule for Savolitinib in Combination with Osimertinib
A Shahraz, H Liu, D Olabode, R Jones, K Miah, A Phipps, ...
Thirteenth American Conference on Pharmacometrics (ACoP13), 2022
2022
Population Pharmacokinetics Analysis of AZD0171, an Anti-LIF Antibody in Patients with Advanced Solid Tumors
A Shahraz, H Huan Liu, Y Chen, K Vishwanathan
12th American Conference on Pharmacometrics (ACoP12), 2021
2021
系统目前无法执行此操作,请稍后再试。
文章 1–20